The price Eli Lilly is paying for protein drug developer and portfolio company Protomer could potentially top $1bn dependent on milestone payments.

Electric aircraft developer Heart Aerospace raised $35m from investors including Mesa Air and United, while several corporates are set to exit remote access software developer Openpath.

MIT’s battery technology spinout will collect $200m in a private investment in public equity financing and list on the New York Stock Exchange.

General Motors, Hyundai, Kia, Geely, SAIC Motor, Koch Industries, Foxconn and LG took part in a $200m PIPE supporting a $3.6bn reverse merger for lithium-metal battery developer SES.

Microsoft is reportedly paying over $500m for the MassMutual Ventures and National Grid Partners-backed cybersecurity software provider.

Block.one's blockchain technology spinoff is joining forces with publicly listed Far Peak Acquisition Corporation at a $9bn valauation.

Munich Re and Microsoft helped CO2-to-chemicals technology provider Twelve raise $57m while Eli Lilly and Kaiser Permanente-backed CRO dMed-Clinipac secured $50m.

The blockchain payment technology provider is set to undergo a $4.5bn reverse takeover having previously secured over $680m from investors including FTX, Baidu, Bitmain, CreditEase and Wanxiang.

Medison has contributed to a private placement in support of portfolio company Alpha Tau Medical’s $1bn reverse merger with Healthcare Capital Corp.

VIB and V-Bio Ventures have both participated in a series A round for Muna Therapeutics, the result of a merger of two recent spinouts.